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Altered expression of immune modulator and structural genes Severe congenital obstructive uropathy, one of the most
in neonatal unilateral ureteral obstruction. common causes of chronic renal failure in children, re-
Background. Congenital obstructive nephropathy is a condi- sults in hydronephrosis, tubular dilatation, cyst forma-tion characterized by hydronephrosis, tubular dilatation, apo-
tion, and renal parenchymal damage [1–3]. Because se-ptosis, and atrophy, as well as interstitial cellular infiltration
and progressive interstitial fibrosis. The renal consequences of vere congenital obstructive uropathy is a progressive
chronic unilateral ureteral obstruction (UUO) in the neonatal anomaly, most children will require renal replacement
rat are similar to those of clinical congenital obstructive ne- therapy and renal transplantation.phropathy.
The neonatal rat serves as a model to study develop-Methods. To define alterations in renal gene expression in-
duced by chronic neonatal UUO, Sprague-Dawley rats were mental renal anomalies. Only about 10% of the nephrons
subjected to UUO or sham operation within the first 2 days are present at birth, and by 2 weeks postnatally, nephro-
of life, and kidneys were harvested after 12 days.
genesis is complete. Therefore, the immediate postnatalResults. Microarray analysis revealed that the mRNA expres-
period in the rat is analogous to midgestation in thesion of multiple immune modulators, including krox24, inter-
feron- regulating factor-1 (IRF-1), monocyte chemoattractant human [4], thus making neonatal unilateral ureteral ob-
protein-1 (MCP-1), interleukin-1 (IL-1), CCAAT/enhancer struction (UUO) a useful model to study severe congeni-
binding protein (C/EBP), p21, c-fos, c-jun, and pJunB, was
tal obstructive uropathy.significantly increased in obstructed compared to sham-oper-
There are multiple growth factors and other compoundsated kidneys (all P  0.05). Western blot analysis revealed
significant changes in immune modulator protein abundance whose expression is abnormal after neonatal UUO. There
in the obstructed versus sham-operated kidney for krox24 (P is increased expression of transforming growth factor-beta
0.0004), IRF-1 (P  0.005), MCP-1 (P  0.01), and JunD (P 
(TGF-), platelet-derived growth factor (PDGF), kera-0.0008). Alternatively, the abundance of all of the immune
tinocyte growth factor (KGF), and hepatocyte growthmodulator proteins was similar in sham-operated and ob-
structed kidneys in rats subjected to acute (4 days) neonatal factor (HGF) after neonatal UUO [5–10]. In addition,
UUO. Microarray analysis studies also reveal that structural there is increased expression and secretion of renin from
genes that comprise the cytoskeleton and cell matrix are sig-
the obstructed kidney [11]. The content of clusterin is in-nificantly up-regulated by chronic neonatal UUO, including
creased in the obstructed kidney [12]. On a cellular level,calponin, desmin, dynamin, and lumican (all P  0.05).
Conclusion. Multiple genes are aberrantly expressed in the several changes occur after neonatal UUO. First, kidney
kidney of rats subjected to chronic neonatal UUO. Elucidation DNA content is reduced in kidneys subjected to neonatalof these genes involved in neonatal UUO may lead to new
UUO [13]. Also present in the obstructed kidney is ainsight about congenital obstructive nephropathy.
massive infiltration of leukocytes [13]. Finally, neonatal
UUO results in altered rates of apoptosis, or programmed
Congenital obstructive uropathy comprises the struc- cell death [14]. Histologically, the obstructed kidney re-
tural and functional changes in the urinary tract that veals a proliferative process. Early after neonatal UUO,
develop in utero and lead to reduced renal function. the kidney is flooded with inflammatory mediators, in-
cluding lymphocytes and macrophages [15, 16]. However,
Key words: neonatal, ureteral, obstruction, gene, protein, expression. even after relief of chronic neonatal UUO, the kidney
continues to exhibit inflammation and interstitial fibrosis,Received for publication September 16, 2002
suggesting an ongoing inflammatory process [17–19].and in revised form November 13, 2002
Accepted for publication February 28, 2003 We speculate that additional factors participate in the
pathogenesis of chronic neonatal UUO. To this end, we 2003 by the International Society of Nephrology
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Table 3. Expression of genes previously shown to be aberrantlyTable 1. Immune modulator gene expression after 12 days neonatal
unilateral ureteral obstruction (UUO) expressed in neonatal unilateral ureteral obstruction (UUO) as
analyzed by microarray analysis
mRNA Expression
Fold-change Fold-change
Gene Sham UUO (obstructed vs. sham) P value Gene (obstructed vs. sham) P value
Krox24 1612140 7515419 4.7 0.0002 Clusterin 10.6 0.001
MCP-1 485159 93823241 21.9 0.001 Epidermal growth factor (EGF) 26.1 0.004
IRF-1 1187382 5335755 5.8 0.008 Heat shock protein-27 (HSP-27) 10.7 0.007
IL-b1 20887 93781 3.7 0.004 Renin 5.9 0.02
C/EBP 306 630145 4.6 0.01 Smooth muscle actin 30.7 0.03
c-fos 1806465 3974576 2.5 0.04 Transforming growth factor-
c-jun 43485 1250159 3.1 0.01 (TGF-) 5.9 0.009
p21 3510 43842 5.9 0.0007
The mRNA expression of these genes was determined by microarray analysis.pJunB 641122 2908739 4.8 0.04
Data are expressed as the fold-change in relative mRNA expression in neonatalJunD 490180 844228 1.5 0.1
obstructed compared to sham-operated kidneys. There is a significant (P  0.05)
Data are shown in two ways: mRNA expression in sham-operated and ob- change in mRNA expression of all genes shown in the obstructed kidney.
structed kidneys, and the fold-change between the two conditions. There is a signifi-
cant (P  0.05) up-regulation in mRNA expression in the obstructed kidney for
all genes except JunD. Abbreviations are: MCP-1, monocyte chemoattractant
protein-1; IRF-1, interferon- regulatory factor-1; IL-b1, interleukin-1; C/EBP, guanidinium thiocyanate. Total RNA was extracted from
CCAAT/enhancer binding protein.
the tissue using the acid guanidinium isothiocyanate-
phenol-chloroform extraction procedure. A total of three
Table 2. Cytoskeleton gene expression in neonatal unilateral pairs (sham-operated and UUO) of kidneys were in-
ureteral obstruction (UUO) cluded for microarray analysis. All samples were run in
duplicate.Fold-change
Gene (obstructed vs. sham) P value cDNA and cRNA synthesis. RNA was synthesized with
Calponin 10.9 0.002 total RNA as a template by using SuperScript Choice
Desmin 7.1 0.0004 System for cDNA synthesis (Gibco/BRL, Gaithersburg,
Dynamin 6.8 0.002
MD, USA) with a T7-(T)24 DNA primer: 5-GGCCAGLumican 6.1 0.003
TGAATTGTAATACGACTCACTATAGGGAGGThe mRNA expression of these genes was determined by microarray analysis.
Data are expressed as the fold-change in relative mRNA expression in neonatal CGG-d(T)24-3. For first-strand cDNA synthesis, a typical
obstructed compared to sham-operated kidneys. There is a significant (P  0.05) 20 uL reaction contained 5 ug RNA, 100 pmol T7-(T)24up-regulation in mRNA expression of all genes shown in the obstructed kidney.
primer, 500 umol/L each desoxynucleoside triphosphate
(dNTP), and 200 U of reverse transcriptase (Superscript
II Reverse) (Gibco/BRL). The reaction was incubatedperformed microarray analysis with the goal of identi-
for 1 hour at 42	C. Second-strand cDNA synthesis wasfying additional genes that contribute to the damage
carried out at 16	C for 2 hours in a total volume of 170observed in chronic neonatal UUO.
uL by using 10 U of Escherichia coli DNA ligase, 40 U
of E. coli DNA polymerase I, and 2 U of E. coli RNase
METHODS H in the presence of 200 umol/L of each dNTP. After
Neonatal UUO second-strand cDNA synthesis, 10 U of T4 DNA poly-
merase was added and the samples incubated for fiveOne day following birth, Sprague-Dawley rat pups
minutes at 16	C. The reaction was stopped by the addi-were anesthetized with isoflurane and oxygen. All were
tion of 0.5 mol/L ethylenediaminetetraacetic acid (EDTA).subjected to UUO of one kidney. Pups were euthanized
Samples were phenol chloroform–extracted using Phase-by sodium pentobarbital overdose on either day 4 (acute
Lock Gel (Eppendorf 05 Prime, Boulder, CO, USA) andneonatal UUO) or day 12 (chronic neonatal UUO). The
precipitated overnight at20	C with 2.5 volume of 100%kidneys were excised, placed in icy normal saline, decap-
ethanol and 0.5 volume of 7.5 mol/L NH4Ac. Biotinyl-sulated, bisected, blotted dry, and weighed. The frozen
ated antisense cRNA was synthesized from the double-kidneys were stored at 80	C until the day of either
stranded DNA template using the Enzo Bioarray High-RNA extraction or protein isolation, whereupon the kid-
Yield RNA Transcript Labeling kit (Affymetrix, Dur-ney was bisected longitudinally and one half was used
ham, NC, USA). Reactions were run according to manu-for RNA extraction and subsequent microarray analysis,
facturer’s directions. The reaction was incubated at 37	Cand the other half was saved for protein isolation.
for 5 hours. Samples were then precipitated overnight
Microarray analysis at –20	C, taken up in 20 uL of diethyl pyrocarbonate
(DEPC)-treated water and spectrophotometrically quan-RNA extraction. The procedure of microarray analy-
tified. Forty micrograms of biotinylated antisense cRNAsis was similar to that used in other studies of gene
was fragmented by heating the sample to 94	C for 35expression analysis in the kidney [20–22]. Sham-operated
and UUO kidney tissue was homogenized in 4 mol/L minutes in a volume of 40 uL The fragmentation buffer
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Table 4. Genes down-regulated in neonatal unilateral ureteral obstruction (UUO)
Fold-change
Gene (obstructed vs. sham) P value
Aquaporin-7 3.38 0.01
Calbindin D28 9.9 0.0002
Glucose-6-phosphatase 46.9 0.002
Kidney-specific androgen-regulated protein (KAP) 20.8 0.008
Organic anion transporter (OAT-K1) 4.9 0.009
Rhodanese 7.9 0.02
Sodium-dependent phosphate transporter (NaPi-2) 7.9 0.02
Sodium-hydrogen exchanger (NHE3) 4.7 0.004
Thiazide-sensitive sodium chloride transporter (TSC) 5.23 0.02
Vasopressin 2 receptor 4.48 0.002
Data are expressed as the fold-change in relative mRNA expression in neonatal obstructed compared to sham-operated kidneys. There is a significant (P  0.05)
down-regulation of all genes shown in the neonatal obstructed kidney.
Table 5. Apoptosis genes down-regulated in neonatal unilateral for 16 hours at 45	C with mixing on a rotisserie at 60
ureteral obstruction (UUO)
rpm. After hybridization, the solutions were removed,
Fold-change arrays were briefly rinsed and washed on a fluidics station
Gene (obstructed vs. sham) P value (Affymetrix). Hybridized arrays were stained for 10 min-
Fas 1.66 0.05 utes at 25	C with streptavidin-R phycoerythrin (Molecu-
Fas ligand 3.26 0.05
lar Probes, Eugene, OR, USA) (10 ug/mL), followed byCD14 2.76 0.05
Angiotensin II receptor 3.01 0.05 staining with biotinylated goat antistreptavidin antibody
Bcl-2 0.99 NS (3 ug/mL) for 10 minutes at 25	C, and then stained onceBax 1.34 NS
again with steptavidin-R phycoerythrin for 10 minutesp38 1.06 NS
Decorin 1.93 0.05 at 25	C.
p53 1.52 0.05 Probe scanning and data analysis. Probe arrays wereeNOS 2.07 0.05
scanned with a confocal laser scanner (Agilent, Palop27(KIP1) 0.54 NS
Alto, CA, USA) at a wavelength of 570 nm. Signal andData are expressed as the fold-change in relative mRNA expression in neo-
natal obstructed compared to sham-operated kidneys. There is a significant (P background intensities were quantified by pixel intensity
0.05) down-regulation of several genes in the neonatal obstructed kidney.
and expression signals were analyzed using commercial
software (Microarray Suite 4.0.1, Affymetrix). Multiple
spots of different intensities were obtained on each array.contained 40 mmol/L Tris-acetate (pH 8.1), 100 mmol/L
Individual cDNA signal intensities were determined fromKOAc, and 30 mmol/L MgOAc.
the mean density within each individual spot. The back-Quality control of samples. The quality of each RNA
ground was measured using the mean pixel intensity ofsamples was verified by running the samples on a 1%
the blank spots in the array (devoid of cDNA). Dataagarose gel. In addition, prior to hybridization, the cDNA
analysis was carried out by using the software, Micro-was hybridized with Affymetrix “Test Chips,” which con-
DataBase 2.0 (Affymetrix) and Data Mining Tools 2.0tained multiple ubiquitous genes, including -actin and
(Affymetrix). For each gene, fold changes were deter-glyceraldehyde-3-phosphate dehydrogenase (GAPDH).
mined according to Affymetrix algorithms and proce-Only cDNA that had superior expression of the test
dures. The calculation of the ratio between perfect matchgenes (3/5 ratio less than 3) was submitted for hybrid-
to mismatch was used to define transcripts as being pres-ization with the Affymetrix GeneChips.
ent or absent [23].Hybridization. Affymetrix GeneChips were prehybrid-
ized with 200 uL hybridization buffer [100 mmol/L
Western blotting2-(N-morpholino)ethanesulfonic acid (MES), 1 mol/L
For isolation of protein, the tissue was homogenized(Na), 20 mmol/L EDTA, and 0.01% Tween 20] for 10
in 250 mmol/L sucrose, 1 mmol/L EDTA, 5 mmol/L Tris,minutes at 45	C in a Affymetrix GeneChips Hybridization
0.5 mmol/L benzamidine HCL, 0.1 mmol/L 1,10 phenan-Oven 640 at 60 rpm. Hybridization was done in a final
throline, 0.5 mg/mL leupeptin, 0.7 mg/mL pepstatin A,volume of 300 uL, containing 15 ug of fragmented biotinyl-
and 0.1 mmol/L phenylmethylsulfonyl fluoride (PMSF).ated cRNA, 50 pmol/L Control Oligonucleotide B2 (Affy-
Cell lysates were then separated on 6% to 18% gradientmetrix), Eukaryotic Hybridization Controls (Affymetrix),
sodium dodecyl sulfate (SDS)-polyacrylamide gels, elec-0.1 mg/mL herring sperm DNA, and 0.5 mg/mL of acety-
trophoretically transferred to nitrocellulose membranes,lated bovine serum albumin (BSA) in 1
 hybridization
blocked in phosphate-buffered saline (PBS)-Tween, andbuffer. The samples were heated to 95	C for 5 minutes
and briefly spun down. Hybridizations were carried out immunoblotted with antisera to the antigen under study,
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Fig. 1. Analyses of select immune modulator genes after chronic (12
days) neonatal unilateral ureteral obstruction (UUO). (A ) Representa-
tive Western blot analysis of multiple genes in sham-operated, unob-
structed (contralateral to obstructed), and neonatal obstructed kidneys.
Abbreviations are: MCP-1, monocyte chemoattractant protein-1; IRF-1
interferon- regulatory factor-1; IL-1, interleukin-1, C/EBP, CCAAT/
enhancer binding protein. (B) Densitometry of Western blot of IRF-l/
glyeraldehyde-3-phosphate dehydrogenase (GAPDH), MCP-1/GAPDH,
and krox24/GAPDH on sham-operated, unobstructed, and obstructed
kidneys.
and diluted 1:100. All primary antibodies (added 1:100) TBST and then processed for chemiluminescence detec-
tion using the ECL Plus detection system (Amersham,and secondary immunoglobulin G (IgG) (added 1:20,000)
were purchased from Santa Cruz Biotechnology (Santa Upsala, Sweden). The membranes were then exposed to
Kodak Biomax ML film (Eastman Kodak, Rochester,Cruz, CA, USA). A list of the antibodies used includes
krox24, monocyte chemoattractant protein-1 (MCP-1), NY, USA). Tissue from seven sham-operated and seven
animals exposed to UUO (ipsilateral and contralateralinterferon- regulating factor-1 (IRF-1), interleukin-1
(IL-1), C/EBP, c-fos, c-jun, p21, pJunB, and JunD. kidneys) was included for Western blot analysis from
each time period studied (4 and 12 days postobstruction).The membranes were then washed with three changes
of Tris-buffered saline with 0.1% Tween (TBST) after
Statistical analysiswhich a 1:20,000 dilution of horseradish peroxidase (HRP)-
linked secondary antibody was incubated with the mem- For microarray analysis, statistical significance was as-
sessed by the Student t test (P  0.05). Data were ex-branes for 20 minutes at room temperature. The mem-
branes were then washed again with three changes of pressed as mean SE Densitometric values from scanned
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Fig. 1. Continued. (C ) Densitometry of Western blot of C/EBP/
GAPDH and IL-1/GAPDH on sham-operated, unobstructed, and
obstructed kidneys. (D ) Densitometry of Western blot of p21/GAPDH,
c-jun/GAPDH, and c-fos/GAPDH on sham-operated, unobstructed,
and obstructed kidneys.
immunoblots were determined and the data are expressed
as mean SE Groups were compared by one-way analy-
sis of variance (ANOVA) with Bonferroni’s multiple
comparison test. Significance is defined as P  0.05.
RESULTS
Microarray analysis results: Chronic neonatal UUO
Twelve days after neonatal UUO, the animals were
sacrificed and the kidneys were excised. On sham-oper-
ated and obstructed kidneys, we performed microarray
analysis. Over 8000 genes were analyzed on the array.
There are over 250 genes whose expression is signifi-
Fig. 2. Densitometry of Western blot analysis of select immune modu-
lator genes after chronic (12 days) neonatal unilateral ureteral obstruc-
tion (UUO). Western blots were scanned and data are represented as
a ratio of protein abundance between each gene [corrected by glyceral-
dehyde-3-phosphate dehydrogenase (GAPDH)] in sham-operated, contra-
lateral, and neonatal obstructed kidneys. One-way analysis of variance
(ANOVA) with Bonferroni’s multiple comparison test reveals significant
up-regulation of protein abundance in obstructed versus sham-operated
kidneys for krox24, monocyte chemoattractant protein-1 (MCP-1), inter-
feron- regulatory factor-1 (IRF-1), and JunD (all P  0.05).
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Fig. 3. Analyses of select immune modulator genes after acute (4 days)
neonatal unilateral ureteral obstruction (UUO). (A ) Representative
Western blot analysis of multiple genes in sham-operated, unobstructed
(contralateral to obstructed), and neonatal obstructed kidneys. Abbre-
viations are: MCP-1, monocyte chemoattractant protein-1; IRF-1 inter-
feron- regulatory factor-1; IL-1, interleukin-1, C/EBP, CCAAT/
enhancer binding protein. (B) Densitometry of Western blot of IRF-l/
glyeraldehyde-3-phosphate dehydrogenase (GAPDH), MCP-1/GAPDH,
and krox24/GAPDH on sham-operated, unobstructed, and obstructed
kidneys.
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Fig. 3. Continued. (C) Densitometry of Western blot of c-fos/GAPDH,
C/EBP/GAPDH and IL-1/GAPDH on sham-operated, unobstructed,
and obstructed kidneys. (D ) Densitometry of Western blot of p21/
GAPDH and c-jun/GAPDH on sham-operated, unobstructed, and ob-
structed kidneys.
cantly increased or decreased in the obstructed kidney, tion, the expression of multiple genes is significantly de-
creased in the obstructed kidney, including several genesand we focused on groups of genes that participated in
similar or shared biochemical pathways or processes. that regulate sodium and water transport in the kid-
ney: the sodium-dependent phosphate transporter-2Our studies reveal that the expression of multiple im-
mune modulator genes is significantly increased in the (NaPi-2), the thiazide-sensitive sodium chloride trans-
porter (TSC), the vasopressin 2 receptor, and the sodiumobstructed kidney. The results of 10 genes, all of which
participate in the immune response are shown in Table 1. hydrogen exchanger-3 (NHE3) (Table 4). Finally, since
apoptosis is a major feature of neonatal UUO [3], weThese genes include those that encode for krox24, MCP-1,
IRF-1, IL-1b, C/EBP, c-fos, c-jun, p21, pJunB, and JunD. were interested in several genes that induce apoptosis
(Table 5). Our results show that the expression of severalFor all of these genes except JunD, there is a significant
increase in mRNA expression in the obstructed kidney. proapoptosis genes is increased in the obstructed kidney,
including p53, endothelial nitric oxide synthase (eNOS),We also observed that several genes that comprise
the cytoskeleton or regulate its function are aberrantly and Fas ligand, although there are no changes in bcl-2
and Bax, two potent proapoptosis genes [24].expressed in the obstructed kidney, including genes that
encode for calponin, desmin, dynamin, and lumican (Ta-
Western blot analysisble 2). Serving as a positive control for the microarray
procedure, we also searched for genes that prior studies Because progressive renal injury from congenital ob-
structive uropathy is linked to interstitial inflammation,showed are aberrantly expressed in neonatal UUO. Sev-
eral of these genes are presented in Table 3, including we performed Western blot analysis of the immune mod-
ulators identified by microarray analysis. The results oftransforming growth factor- (TGF-), alpha smooth
muscle actin (a-SMA), and heat shock protein. In addi- these studies are shown in Figures 1 and 2. Figure 1
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DISCUSSION
Chronic neonatal UUO in the rat is an established
model of human obstructive uropathy [17, 18, 26]. Many
genes are abnormally expressed in this model [5–16].
We used the protocol of microarray analysis to identify
supplementary genes that are abnormally expressed in
chronic neonatal UUO. The micorarray analysis proce-
dure has previously been used to study gene expression
in a wide variety of tissues, including the kidney [20–22].
While the expression of many genes was altered in
the chronic neonatal obstructed kidney, we were most
intrigued by the abnormal expression of transcription
factors that activate the immune response since it has
been shown that there is an inflammatory process that
occurs in acute and chronic neonatal UUO [3, 18]. The
role of the immune modulators we identified has not yet
been studied in either acute or chronic neonatal UUO.
Our studies demonstrate that the mRNA expression of
10 genes is significantly increased in chronic neonatal
UUO. The increased expression of these genes after
Fig. 4. Densitometry of Western blot analysis of select immune modu- chronic neonatal UUO mirrors that of several other
lator genes after acute (4 days) neonatal unilateral ureteral obstruction
genes in this condition, including epidermal growth fac-(UUO). Western blots were scanned and data are represented as a
ratio of protein abundance between each gene (JunD and pJunB) [cor- tor (EGF), renin, clusterin, TGF-, and -SMA [2, 27].
rected by glyceraldehyde-3-phosphate dehydrogenase (GAPDH)] in The changes in mRNA expression of IL-1, p21, c-jun,
sham-operated, contralateral, and neonatal obstructed kidneys. One-
and c-fos are not unique to neonatal UUO. Indeed, theway analysis of variance (ANOVA) with Bonferroni’s multiple compari-
son test reveals no significant changes in all proteins studied in ob- expression of IL-1, p21, c-jun, and c-fos are abnormal
structed versus sham-operated kidneys. in adult UUO [28–30].
Our studies also are the first to reveal significant changes
in protein abundance for krox24, MCP-1, IRF-1, and
is a composite of representative Western blots for 10 JunD after chronic neonatal UUO. Alternatively, whereas
proteins in kidneys subjected to chronic neonatal UUO, the expression of several immune modulator proteins
and Figure 2 shows the densitometry of the Western blot appears to rise after acute neonatal UUO, these changes
studies. For these studies, we measured protein abun- are not statistically significant, suggesting that the activa-
dance in sham-operated (sham), unobstructed (contra- tion of some immune modulator genes is a time-related
lateral to obstructed) and obstructed kidneys. Although phenomenon. One interpretation of these findings is that
JunD mRNA expression was not significantly up-regu- the immune modulator genes do not play a major role
lated in the obstructed neonatal kidney, we included the in the proliferative process observed in UUO [15, 16],
analysis of the JunD protein in these studies because but rather, participate in the development of the chronic
along with c-fos, c-jun, and pJunB, it is part of the activa- inflammation and interstitial fibrosis in chronic neonatal
tor protein-1 (AP-1) complex [25]. Our results reveal
UUO [17, 18].that the protein abundance for krox24 (0.0004), MCP-1
Krox24 (nerve growth factor I-A, or early growth fac-(0.01), IRF-1 (0.005), and JunD (0.0008) is significantly
tor-1) stimulates proliferation and macrophage differen-increased in the obstructed versus sham-operated kidney
tiation [31–33]. Krox24 may also play a role in apoptosisafter chronic neonatal UUO.
[34]. The krox24 consensus target sequence has beenTo test if the change in protein abundance of the
identified in the promoter regions of various growth fac-immune modulator genes was a time-specific phenome-
tors, including TGF- and PDGF [35], both of whichnon, we performed Western blot analysis of the 10 genes
are up-regulated in neonatal UUO [7]. Thus, up-regula-in kidney subjected to acute (4 days) neonatal UUO. As
tion of krox24 may result in increased production ofshown in Figure 3 (Western blot) and Figure 4 (accompa-
these proinflammatory growth factors and may simulta-nying densitometry) the abundance of several proteins
neously induce increased rates of cell death in the ob-appears to be higher in the obstructed kidney, although
structed kidney.none of these changes reached statistical significance.
MCP-1 stimulates macrophage accumulation and at-Thus, the change in krox24, MCP-1, IRF-1, and JunD
tracts basophils and T lymphocytes to areas of inflam-protein abundance is a phenomenon that occurs only
after chronic neonatal UUO. mation [36]. Its role in adult UUO has been previously
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established [37], and its levels are increased in the urine regulated in the obstructed kidney. Although the expres-
sion of these genes has not been explored in neonatalof patients with congenital obstructive uropathy [38].
MCP-1 can induce apoptosis as was demonstrated in vas- UUO, their aberrant expression is not unexpected since
sodium and water regulation is abnormal in the ob-cular smooth muscle [39]. It seems reasonable to hypoth-
esize that the role of MCP-1 in the pathogenesis of neo- structed kidney of the neonatal rat [54, 55]. Finally, since
apoptosis is a major feature in neonatal UUO [3], wenatal UUO may be to induce macrophage infiltration and
subsequent tubular apoptosis ad interstitial fibrosis [40]. were interested in several genes that induce apoptosis.
Indeed, p53, eNOS, and Fas ligand are all up-regulated inIRF-1 mediates the activities of nuclear factor-kappa
B (NF-B) [41] and interferon- [42], and potentiates the obstructed kidney, although there are no changes in
bcl-2 and Bax, genes that are potent apoptosis genes [25].granulocyte differentiation [43]. Similar to krox24 and
MCP-1, IRF-1 stimulates apoptosis through nitric oxide The changes in the immune modulator gene expres-
sion in neonatal UUO do not appear to represent indis-[44]. IRF-1 may participate in the pathogenesis of neo-
natal UUO by stimulating inflammation and apoptosis. criminate occurrences. Indeed, our microarray analysis
studies reveal markedly different expression patterns ofJunD protein abundance but not mRNA expression
is increased in the obstructed neonatal kidney, suggesting immune modulator genes in neonatal UUO as compared
to those identified by Yohsida et al [56] in renal ischemia/posttranscriptional regulation of the mRNA. JunD is a
transcription factor for AP-1, a major component of the reperfusion. For example, several immune modulators
up-regulated in ischemia/reperfusion, including CD68immune response [24]. JunD is activated by various cyto-
kines, including tumor necrosis factor- (TNF-) and antigen, colony-stimulating factor receptor, and vascular
cell adhesion molecule-1 (VCAM-1), are not up-regu-IL-1 [45, 46]. In addition, JunD can activate cytokines,
most notably TGF- [47]. Finally, JunD is a transcription lated in neonatal UUO.
factor for the proinflammatory substance NF-B [48].
However, in contrast to krox24, MCP-1, and IRF-1, JunD
CONCLUSION
inhibits apoptosis [49]. JunD may play a role in the pro-
We speculate that krox24, MCP-1, IRF-1, and JunDgression of damage in neonatal UUO by stimulating
may contribute to the interstitial inflammatory processproliferation, although it may provide some protection
that occurs in chronic neonatal UUO. Furthermore, somein neonatal UUO by inhibiting cell death.
of these genes may play a role in cell viability by regulat-Our microarray studies also show that genes that par-
ing apoptosis. Elucidation of specific immune modula-ticipate in the building or regulation of the cytoskeleton
tors or structural genes involved in chronic neonataland extracellular matrix are abnormally expressed in the
UUO may lead to new insight in the pathogenesis andneonatal obstructed kidney, including calponin, desmin,
management of congenital obstructive nephropathy.dynamin, and lumican. This is supportive of studies that
show an increase in the extracellular matrix in neonatal
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